This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

A look at IMU-935, a RORγt inverse agonist for the treatment of moderate-severe psoriasis

Ticker(s): IMUX

Who's the expert?

Institution: Yale

  • Assistant Professor of Medicine at Yale, Board certified dermatologist and dermatopathalogist.
  • Specializes in evaluation and treatment of patients with inflammatory skin disorders, especially cutaneous granulomatous diseases such as sarcoidosis and granuloma annulare.
  • Interested in the identification and evaluation of new treatment approaches for inflammatory skin diseases and conducts clinical trials in this area.

Interview Goal
Discuss the target with a dermatologist

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.


*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.